DGAP-News: Jupiter Wellness's Booster Drug Has Potential To Increase Hair Loss Treatments' Efficacy By Enhancing Crucial Enzyme Enrichment Capacity by 7x
Retrieved on:
Tuesday, September 13, 2022
Procter & Gamble Co. v OHIM, Hair loss, SULT1A1, Health, Woman, JNJ, EPA, NYSE, Advertising, Beauty, TaishÅ, Unilever, Company, Population, Intellectual property, Hair, Gambling, Patient, LON, Burns, Dermatitis, OTC, Male, Human, Rogaine, NASDAQ, Self-esteem, Minoxidil, TYO, ULVR, Health minister, Research, Skin, PG, CAGR, Cosmetics, Beauty salon, Fine chemical, Petroleum jelly, Dietary supplement, Pharmaceutical industry, Man
Women sometimes equate a bad hair day with a bad day overall, and the condition of a womans hair can impact confidence.
Key Points:
- Women sometimes equate a bad hair day with a bad day overall, and the condition of a womans hair can impact confidence.
- Hair loss and its treatment have found a prominent place in discussions relating to hair care.
- In the U.S., well-known products for the treatment of hair loss include Johnson & Johnsons (NYSE: JNJ) Rogaine, Vegamour GRO hair serum, and Nutrafol hair growth supplements.
- Jupiter Wellness may have a lucrative addition to hair loss treatments with current minoxidil distributors becoming significant distributors in the future.